1. "General Medicine Services"
  2. "Hematology-Oncology Fellows"
Formats
  1. Meeting Abstract (12)
  2. Journal Article (4)
Groups
  1. GME, Medicine (16)
  2. General Medicine Services (16)
  3. Graduate Medical Education (16)
  4. Hematology-Oncology Fellows (16)
  5. CTCR Scholars (15)
  6. Department of Medicine (15)

More Groups

People
  1. Dhwani Patel (8)
  2. Michael Scordo (8)
  3. Neha Korde (8)
  4. Alexander Lesokhin (7)
  5. Carlyn Rose Tan (7)
  6. David Chung (7)

More People

Years
  1. 2023 (13)
  2. 2022 (1)
  3. 2021 (1)
  4. 2020 (1)
Publications
  1. Journal of Clinical Oncology (5)
  2. Blood (4)
  3. Clinical Lymphoma, Myeloma and Leukemia (2)
  4. Cancer Investigation (1)
  5. Gynecologic Oncology (1)
  6. JNCI: Journal of the National Cancer Institute (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (5)
  2. American Society of Hematology (4)
  3. Elsevier Inc. (3)
  4. Nature Publishing Group (2)
  5. Informa Healthcare (1)
  6. Oxford University Press (1)

Results (16)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Identifying causes of unscheduled healthcare interactions and changes to patient disposition in individuals receiving outpatient commercial bispecific antibody therapy in relapsed/refractory multiple myeloma (RRMM)
    Meeting Abstract

    Howard, A. J.; Shekarkhand, T.; Hamadeh, I. S.; Wang, A.; Patel, D.; Tan, C.; Hultcrantz, M.; Mailankody, S.; Hassoun, H.; Shah, U. A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Patterns of cytokine release syndrome with teclistamab in relapsed/refractory multiple myeloma with or without prior T-cell redirection therapy
    Meeting Abstract

    Hamadeh, I. S.; Shekarkhand, T.; Rueda, C.; Firestone, R.; Wang, A.; Korde, N.; Hultcrantz, M.; Lesokhin, A.; Mailankody, S.; Hassoun, H.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Evaluating tumor-intrinsic and patient-specific mechanisms of resistance to teclistamab in anti-BCMA exposed and naïve multiple myeloma
    Meeting Abstract

    Firestone, R.; McAvoy, D.; Shekarkhand, T.; Serrano, E.; Hamadeh, I. S.; Wang, A.; Zhu, M.; Patel, D.; Tan, C.; Hultcrantz, M.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Clinical outcomes associated with del(17p) in newly diagnosed multiple myeloma treated with triplet and daratumumab-based quadruplet induction regimens
    Meeting Abstract

    Jurgens, E.; Firestone, R.; Maclachlan, K. H.; Nemirovsky, D.; Derkach, A.; Hultcrantz, M.; Hassoun, H.; Mailankody, S.; Shah, U. A.; Rajeeve, S.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Barriers to early detection: Insurance denials for breast MRI screening in women with germline BRCA1/2
    Meeting Abstract

    Gordhandas, S.; Yen, T. T.; Ingber, S.; Kahn, R.; Kayani, S.; Taffuri, A.; Sokolowski, S.; Martinez, D.; Garcia, P.; Mullangi, S.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • Patterns of cytokine release syndrome with teclistamab in relapsed/refractory multiple myeloma with or without prior T-cell redirection therapy
    Meeting Abstract

    Hamadeh, I.; Shekarkhand, T.; Rueda, C.; Firestone, R.; Wang, A.; Korde, N.; Hultcrantz, M.; Lesokhin, A.; Mailankody, S.; Hassoun, H.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save
  • Bispecific T-cell engager response is driven by pre-treatment CD8+ effector memory cells and inhibited by TIGIT+ Tregs in relapsed/refractory multiple myeloma
    Meeting Abstract

    Firestone, R.; McAvoy, D.; Shekarkhand, T.; Serrano, E.; Hamadeh, I.; Wang, A.; Zhu, M.; Patel, D.; Tan, C. R.; Hultcrantz, M.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save
  • Neoplasia risk in patients with Lynch syndrome treated with immune checkpoint blockade
    Journal Article

    Harrold, E. C.; Foote, M. B.; Rousseau, B.; Walch, H.; Kemel, Y.; Richards, A. L.; Keane, F.; Cercek, A.; Yaeger, R.; Rathkopf, D.; more...
    Nature Medicine (2023)

    Fulltext@MSK | Save
  • Effect of somatic-germline genomic integration on the contribution of pathogenic germline genetic variants (gPV) to colorectal cancer (CRC) carcinogenesis
    Meeting Abstract

    Harrold, E.; Walch, H. S.; Chatila, W. K.; Kemel, Y.; Borio, M.; Maio, A.; Khurram, A.; Salo-Mullen, E. E.; Latham, A.; Murciano-Goroff, Y. R.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Clinical and molecular characterization of microsatellite stable (MSS) tumors in patients with Lynch syndrome (LS)
    Meeting Abstract

    Harrold, E.; Vanderbilt, C.; Maio, A.; Borio, M.; Ranganathan, M.; Sheehan, M.; O'Connor, C.; Murciano-Goroff, Y. R.; Walsh, M. F.; Will, M.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save